Taysha Gene Therapies Inc. (TSHA) NASDAQ

$1.21 0.03 (2.54%)

Market Cap: $75.56M

As of 02/03/23 04:00 PM EST. Market closed.

(TSHA)

Taysha Gene Therapies Inc. (TSHA) NASDAQ

$1.21 0.03 (2.54%)

Market Cap: $75.56M

As of 02/03/23 04:00 PM EST. Market closed.

Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, Taysha aims to rapidly translate our treatments from bench to bedside. Taysha Gene Therapies has combined its team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an ... read more

Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, Taysha aims to rapidly translate our treatments from bench to bedside. Taysha Gene Therapies has combined its team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, Taysha Gene Therapies leverages its fully integrated platform—an engine for potential new cures—with a goal of dramatically improving patients’ lives. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
178
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$1.21
Previous Close
$1.18
Days Range
$1.16 - $1.27
52 week range
$1.06 - $8.48
Volume
757,157
Avg. Volume (30 days)
818,623
Market Cap
$75.56M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
62,442,281
Open
$1.21
Previous Close
$1.18
Days Range
$1.16 - $1.27
52 week range
$1.06 - $8.48
Volume
757,157
Avg. Volume (30 days)
818,623
Market Cap
$75.56M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
62,442,281

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TAYSHA GENE THERAPIES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Manning Paul BDirectorOct 31, 2022 Buy$2.001,500,0003,000,0001,642,202Nov 02, 2022, 04:09 PM
Alam KamranChief Financial OfficerAug 23, 2022 Sale$3.473,32511,538266,121Aug 24, 2022, 04:47 PM
Alam KamranChief Financial OfficerAug 19, 2022 Sale$3.7511,48243,058279,163Aug 22, 2022, 08:05 PM
Alam KamranChief Financial OfficerAug 18, 2022 Sale$3.877,47628,932290,645Aug 22, 2022, 08:05 PM
Alam KamranChief Financial OfficerAug 22, 2022 Sale$3.509,71734,010269,446Aug 22, 2022, 08:05 PM
PRASAD SUYASHCMO and Head of R&DJul 06, 2022 Sale$3.798,95633,943530,589Jul 07, 2022, 04:30 PM
PRASAD SUYASHCMO and Head of R&DJul 05, 2022 Sale$3.513,90513,707539,545Jul 07, 2022, 04:30 PM
PRASAD SUYASHCMO and Head of R&DJul 01, 2022 Sale$3.5323,92384,448543,450Jul 01, 2022, 06:55 PM
PRASAD SUYASHCMO and Head of R&DJun 30, 2022 Sale$3.7213,89251,678567,373Jul 01, 2022, 06:55 PM
PRASAD SUYASHCMO and Head of R&DJun 29, 2022 Sale$3.8112,32446,954581,265Jul 01, 2022, 06:55 PM
Manning Paul BDirectorFeb 03, 2022 Buy$7.8426,602208,5602,091,704Feb 04, 2022, 08:28 AM
Manning Paul BDirectorFeb 03, 2022 Buy$7.8450,000392,000142,202Feb 04, 2022, 08:28 AM
Manning Paul BDirectorFeb 02, 2022 Buy$7.7767,000520,5902,065,102Feb 04, 2022, 08:28 AM
Manning Paul BDirectorFeb 02, 2022 Buy$7.7758,000450,66092,202Feb 04, 2022, 08:28 AM
Nagendran SukumarDirectorFeb 02, 2022 Buy$8.0110,00080,10029,226Feb 03, 2022, 09:21 AM
Donenberg Phillip B.DirectorFeb 02, 2022 Buy$7.783,00023,3403,000Feb 03, 2022, 07:04 AM
Session R.A. IIPresident and CEONov 23, 2021 Buy$12.4442,518529,1029,190,920Dec 08, 2021, 04:05 PM
Manning Paul BDirectorNov 24, 2021 Buy$13.192,20229,04434,202Nov 29, 2021, 05:01 PM
Manning Paul BDirectorNov 23, 2021 Buy$12.5420,000250,80032,000Nov 24, 2021, 07:58 AM
Alam KamranChief Financial OfficerAug 20, 2021 Sale$16.7811,840198,649300,215Aug 20, 2021, 05:52 PM
Alam KamranChief Financial OfficerAug 19, 2021 Sale$16.479,967164,175310,574Aug 20, 2021, 05:52 PM
Alam KamranChief Financial OfficerAug 18, 2021 Sale$17.3511,193194,199319,928Aug 20, 2021, 05:52 PM
PRASAD SUYASHCMO and Head of R&DJul 01, 2021 Sale$21.1219,706416,191593,589Jul 01, 2021, 06:32 PM
PRASAD SUYASHCMO and Head of R&DJun 30, 2021 Sale$21.7920,076437,494619,997Jul 01, 2021, 06:32 PM
PRASAD SUYASHCMO and Head of R&DJun 29, 2021 Sale$23.8239,218934,251637,533Jul 01, 2021, 06:32 PM
Manning Paul BDirectorMay 14, 2021 Buy$20.9812,000251,76012,000May 17, 2021, 07:48 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Manning Paul BDirector10/31/20223,000,000
Alam KamranChief Financial Officer08/23/202211,538
Alam KamranChief Financial Officer08/19/202243,058
Alam KamranChief Financial Officer08/18/202228,932
Alam KamranChief Financial Officer08/22/202234,010
PRASAD SUYASHCMO and Head of R&D07/06/202233,943
PRASAD SUYASHCMO and Head of R&D07/05/202213,707
PRASAD SUYASHCMO and Head of R&D07/01/202284,448
PRASAD SUYASHCMO and Head of R&D06/30/202251,678
PRASAD SUYASHCMO and Head of R&D06/29/202246,954
Manning Paul BDirector02/03/2022208,560
Manning Paul BDirector02/03/2022392,000
Manning Paul BDirector02/02/2022520,590
Manning Paul BDirector02/02/2022450,660
Nagendran SukumarDirector02/02/202280,100
Donenberg Phillip B.Director02/02/202223,340
Session R.A. IIPresident and CEO11/23/2021529,102
Manning Paul BDirector11/24/202129,044
Manning Paul BDirector11/23/2021250,800
Alam KamranChief Financial Officer08/20/2021198,649
Alam KamranChief Financial Officer08/19/2021164,175
Alam KamranChief Financial Officer08/18/2021194,199
PRASAD SUYASHCMO and Head of R&D07/01/2021416,191
PRASAD SUYASHCMO and Head of R&D06/30/2021437,494
PRASAD SUYASHCMO and Head of R&D06/29/2021934,251
Manning Paul BDirector05/14/2021251,760
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2022
06/30/2022
1.53%
1Q
09/30/2022
03/31/2022
4.16%
2Q
09/30/2022
12/31/2021
5.61%
3Q
09/30/2022
06/30/2021
6.78%
5Q
09/30/2022
03/31/2021
7.49%
6Q
Load More

Period of Report: 09/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2022
1.53%
1Q
03/31/2022
4.16%
2Q
12/31/2021
5.61%
3Q
06/30/2021
6.78%
5Q
03/31/2021
7.49%
6Q
Load More